Application of liposomal technologies for delivery of platinum analogs in oncology
Open Access
- 1 August 2013
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 8, 3309-19
Abstract
Peer reviewed article authored by (Liu D, He C, Wang AZ, Lin W). Read article or submit your manuscript for publishing.Keywords
This publication has 85 references indexed in Scilit:
- Zr- and Hf-based nanoscale metal–organic frameworks as contrast agents for computed tomographyJournal of Materials Chemistry, 2012
- Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.2010
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerBritish Journal of Cancer, 2006
- Acoustically active liposomes for drug encapsulation and ultrasound-triggered releaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissueBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicityNature Medicine, 2002
- Clinical development of platinum complexes in cancer therapy: an historical perspective and an updateEuropean Journal of Cancer, 1998
- Treatment of testicular cancer: a new and improved model.Journal of Clinical Oncology, 1990
- INCREASED CYTO-TOXICITY AND REVERSAL OF RESISTANCE TO CIS-DIAMMINEDICHLORO-PLATINUM(II) WITH ENTRAPMENT OF CIS-BIS-NEODECANOATO-TRANS-R,R-1,2-DIAMINOCYCLOHEXANEPLATINUM(II) IN MULTILAMELLAR LIPID VESICLES1988